# Fallen Angel Drugs - Optimization Summary

**Generated:** 2025-11-17 00:31:43

**Total Drugs:** 23
**Successful:** 23
**Errors:** 0

---

## Successfully Processed

| # | Drug | Task | Output File |
|---|------|------|-------------|
| 1 | Tarenflurbil (Flurizan) | BBBP | [01_Tarenflurbil_Flurizan.md](01_Tarenflurbil_Flurizan.md) |
| 2 | Gavestinel (GV-150,526) | BBBP | [02_Gavestinel_GV-150526.md](02_Gavestinel_GV-150526.md) |
| 3 | NXY-059 (Cerovive) | BBBP | [03_NXY-059_Cerovive.md](03_NXY-059_Cerovive.md) |
| 4 | PF-03758309 (PF-3758309) | HIA | [04_PF-03758309_PF-3758309.md](04_PF-03758309_PF-3758309.md) |
| 5 | Olcegepant (BIBN-4096BS) | HIA | [05_Olcegepant_BIBN-4096BS.md](05_Olcegepant_BIBN-4096BS.md) |
| 6 | EPI-506 (ralaniten acetate / prodrug of EPI-002) | HIA | [06_EPI-506_ralaniten_acetate__prodrug_of_EPI-002.md](06_EPI-506_ralaniten_acetate__prodrug_of_EPI-002.md) |
| 7 | KPT-9274 | HIA | [07_KPT-9274.md](07_KPT-9274.md) |
| 8 | Valeresol | HIA | [08_Valeresol.md](08_Valeresol.md) |
| 9 | Fialuridine (FIAU) | DILI | [09_Fialuridine_FIAU.md](09_Fialuridine_FIAU.md) |
| 10 | Ximelagatran (Exanta / oral direct thrombin inhibitor) | DILI | [10_Ximelagatran_Exanta__oral_direct_thrombin_inhibitor.md](10_Ximelagatran_Exanta__oral_direct_thrombin_inhibitor.md) |
| 11 | Fasiglifam (TAK-875) | DILI | [11_Fasiglifam_TAK-875.md](11_Fasiglifam_TAK-875.md) |
| 12 | Lapaquistat acetate (TAK-475) | DILI | [12_Lapaquistat_acetate_TAK-475.md](12_Lapaquistat_acetate_TAK-475.md) |
| 13 | Danuglipron (Pfizer) | DILI | [13_Danuglipron_Pfizer.md](13_Danuglipron_Pfizer.md) |
| 14 | Rosiglitazone | BBBP | [14_Rosiglitazone.md](14_Rosiglitazone.md) |
| 15 | Paclitaxel / other taxanes | BBBP | [15_Paclitaxel__other_taxanes.md](15_Paclitaxel__other_taxanes.md) |
| 16 | Mibefradil (Posicor) | CYP3A4 | [16_Mibefradil_Posicor.md](16_Mibefradil_Posicor.md) |
| 17 | Nefazodone (Serzone) | CYP3A4 | [17_Nefazodone_Serzone.md](17_Nefazodone_Serzone.md) |
| 18 | GSK1059615 | HIA | [18_GSK1059615.md](18_GSK1059615.md) |
| 19 | Neflamapimod (VX-745) | HIA | [19_Neflamapimod_VX-745.md](19_Neflamapimod_VX-745.md) |
| 20 | SAR260301 | CYP3A4 | [20_SAR260301.md](20_SAR260301.md) |
| 21 | Taranabant (MK-0364) | DILI | [21_Taranabant_MK-0364.md](21_Taranabant_MK-0364.md) |
| 22 | NYX-059 | BBBP | [22_NYX-059.md](22_NYX-059.md) |
| 23 | AZD-3514 | HIA | [23_AZD-3514.md](23_AZD-3514.md) |

## Errors

_None_

---

## Configuration

- **Number of beams:** 12
- **Depth:** 3
- **CSV source:** /shared/nas2/knguye71/mCLM_nov/fallenangel.csv

## Features Included

Each slide includes:
- ✅ ADMET score predictions (6 tasks: ames, bbbp, cyp3a4, dili, hia, pgp)
- ✅ QED (drug-likeness) analysis with change tracking
- ✅ **Molecular block count and changes** (shows structural modifications)
- ✅ Step-by-step optimization path with before/after comparisons
- ✅ Safety threshold analysis
- ✅ Overall improvement statistics
